Back to Search

DAVID LAWSON

Day Training/Habilitation Specialist

NPI: 1326696857Individual

Specialties, Licenses & Credentials

Day Training/Habilitation SpecialistPrimary

Day Training/Habilitation Specialist

Code: 373H00000X

00101062165(KS)

Clinical Trials (1)

1
Linked Trials
0
Recruiting
1
With Results

Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment

NCT00352885COMPLETEDPHASE4STUDY_CHAIR

Research & Publications (3)

Antidepressants for the treatment of depression in people with cancer.
PMID 36999619·Cochrane Database Syst Rev·2023
6-review
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
PMID 23575741·Neuropsychopharmacology·2013
2-rct
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
PMID 22353759·Neuropsychopharmacology·2012
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2412 CENTENNIAL BLVD
HAYS, KS 67601

Location

Practice Location

2412 CENTENNIAL BLVD, HAYS, KS
(785) 639-5046

Quick Facts

NPI
1326696857
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Clinical Trials
1
Publications
3

Are you this provider?

Claim Your Profile